Jana Šemberová1, Marcel Brenner2
Anaphylaxis is a clinical emergency and all healthcare professionals should be familiar with its acute and ongoing management. The Guidelines have been prepared by the European Academy of Allergy and Clinical Immunology (EAACI, www.eaaci.org) and World Allergy Organisation (WAO) and have been informed by systematic reviews and the previous guidelines. First-line treatment for anaphylaxis is intramuscular adrenaline. Useful second-line interventions may include removing the trigger, calling for help, correct positioning of the patient, high flow oxygen, intravenous fluids, inhaled short-acting bronchodilatal, nebulized adrenaline and patient monitoring. Discharge arrangements should involve an assessment of the risk of further reactions, a management plan with an anaphylaxis emergency action plan and, where appropriate, prescribing an adrenaline auto-injector with the the device how and when the treatment should be provided. Specialist follow-up is essential to investigate possible triggers with the aim to prevent future episodes. Training for the patient and all caregivers is essential.